http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008517717-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G69-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436 |
| filingDate | 2005-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2008517717-A |
| titleOfInvention | End-capped poly (ester amide) copolymer |
| abstract | End-capped poly (ester amide) (PEA) polymers and methods for making the polymers are provided. The PEA polymer has substantially no terminal active amino groups and / or activated carboxyl groups. The PEA polymer can form a coating for an implantable device, an example of which is a stent. The coating can optionally include a biobeneficial material and / or optionally a bioactive agent. Implantable devices include atherosclerosis, thrombosis, restenosis, bleeding, vascular incision or perforation, aneurysm, vulnerable plaque, chronic total occlusion, lameness, vein and prosthetic anastomosis, biliary obstruction, It can be used for the treatment and prevention of diseases such as ureteral obstruction, tumor obstruction and combinations thereof. [Selection figure] None |
| priorityDate | 2004-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 208.